Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026)

Palvella Therapeutics' (PVLA) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, down 24.9% year-on-year from $1.8 million in Q1 2025, and up 37.11% on a QoQ basis from $1.0 million in Q4 2025.

Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026) Analysis & Trends

Palvella Therapeutics (PVLA) has 14 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets fell 24.9% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 24.9% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 56.23% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $1.4 million, up from $1.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for PVLA reached as high as $11.1 million in Q1 2023 and fell as low as $198000.0 in Q4 2023.
  • Historically, Prepaid Assets has averaged $4.3 million across 5 years, with a median of $2.3 million in 2024.
  • On a YoY basis, Prepaid Assets climbed as much as 1059.6% in 2024 and fell as far as 96.94% in 2024.
  • Year by year, Prepaid Assets stood at $3.2 million in 2022, then slumped by 93.84% to $198000.0 in 2023, then jumped by 1059.6% to $2.3 million in 2024, then plunged by 56.23% to $1.0 million in 2025, then surged by 37.11% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $1.4 million in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Palvella Therapeutics 1.84 Bn 1.57 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.38 Mn
Dec 31, 2025 1.01 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 1.84 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 280,000.00
Jun 30, 2024 649,000.00
Mar 31, 2024 2.97 Mn
Dec 31, 2023 198,000.00
Sep 30, 2023 9.15 Mn
Jun 30, 2023 10.65 Mn
Mar 31, 2023 11.07 Mn
Dec 31, 2022 3.21 Mn
Sep 30, 2022 7.91 Mn
Jun 30, 2022 8.70 Mn
Mar 31, 2022 9.84 Mn
Dec 31, 2021 6.55 Mn
Sep 30, 2021 5.95 Mn
Jun 30, 2021 5.77 Mn